Proliferative Diabetic Retinopathy - High Risk
Conditions
Keywords
Diabetic retinopathy, Laser photocoagulation, Fluorescein angiography
Brief summary
Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic retinopathy are anti-VEGF injection and retinal photocoagulation. The study aims to compare ultra-widefield fluorescein angiography-based targeted retinal photocoagulation and panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
Interventions
Green Laser
Sponsors
Study design
Eligibility
Inclusion criteria
* proliferative diabetic retinopathy (PDR) with neovascularization on the disc or elsewhere in the retina
Exclusion criteria
* Participants with a history of previous history of: * retinal photocoagulation * vitreoretinal surgery * tractional retinal detachment * epiretinal membrane * vitreomacular traction * glaucoma * uveitis * media opacities like cataract, corneal opacity, vitreous hemorrhage * anti-VEGF injections in last 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| BCVA | 2 months | Best Corrected Visual Acuity |
| CMT | 2 months | Central Macular Thickness |
| MD | 2 months | Mean Deviation |
| VFI | 2 months | Visual Filed Index |
Countries
Pakistan